ATE282433T1 - Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden - Google Patents

Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden

Info

Publication number
ATE282433T1
ATE282433T1 AT96902128T AT96902128T ATE282433T1 AT E282433 T1 ATE282433 T1 AT E282433T1 AT 96902128 T AT96902128 T AT 96902128T AT 96902128 T AT96902128 T AT 96902128T AT E282433 T1 ATE282433 T1 AT E282433T1
Authority
AT
Austria
Prior art keywords
oligonucleotides
vinyl alcohol
vinylamine
administration
cationic copolymers
Prior art date
Application number
AT96902128T
Other languages
English (en)
Inventor
Merrill S Goldenberg
Alice C Beekman
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE282433T1 publication Critical patent/ATE282433T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT96902128T 1995-01-25 1996-01-11 Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden ATE282433T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/378,301 US5629184A (en) 1995-01-25 1995-01-25 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
PCT/US1996/000354 WO1996022792A1 (en) 1995-01-25 1996-01-11 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides

Publications (1)

Publication Number Publication Date
ATE282433T1 true ATE282433T1 (de) 2004-12-15

Family

ID=23492568

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96902128T ATE282433T1 (de) 1995-01-25 1996-01-11 Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden

Country Status (16)

Country Link
US (1) US5629184A (de)
EP (1) EP0806966B1 (de)
JP (1) JPH11503407A (de)
AT (1) ATE282433T1 (de)
AU (1) AU701543B2 (de)
BR (1) BR9606783A (de)
CA (1) CA2210875C (de)
DE (1) DE69633852T2 (de)
DK (1) DK0806966T3 (de)
ES (1) ES2233960T3 (de)
IL (1) IL116887A0 (de)
MX (1) MX9705536A (de)
PT (1) PT806966E (de)
SI (1) SI0806966T1 (de)
WO (1) WO1996022792A1 (de)
ZA (1) ZA96401B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US8217015B2 (en) * 2003-04-04 2012-07-10 Arrowhead Madison Inc. Endosomolytic polymers
US20010007771A1 (en) * 1996-05-29 2001-07-12 Sean M. Sullivan Cationic polymers and lipids for the delivery of nucleic acids
US6656508B2 (en) 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
FR2766195A1 (fr) * 1997-07-21 1999-01-22 Transgene Sa Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique
WO1999042091A2 (en) * 1998-02-19 1999-08-26 Massachusetts Institute Of Technology Use of polycations as endosomolytic agents
EP0987029B1 (de) * 1998-08-28 2003-01-22 Transgene S.A. Verwendung eines kationischen Polymer zur Herstellung von Nukleinsäure-Komplexe und verwandte Zusammensetzungen
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
KR100482774B1 (ko) * 2002-09-05 2005-04-14 주식회사 마이진 폴리비닐이미다졸계 화합물을 포함하는 유전자 전달체
US20050025741A1 (en) * 2003-05-15 2005-02-03 Lau Aldrich N.K. Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis
CA2791853C (en) 2010-02-12 2018-03-06 Rhodia Operations Rheology modifier compositions and methods of use
FI20115664A0 (fi) * 2011-06-23 2011-06-23 Kemira Oyj Polymeerituote ja sen käyttö dispergointiaineena
KR20180063885A (ko) 2015-09-24 2018-06-12 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 전이 감소를 위한 방법 및 조성물
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
US11254964B1 (en) * 2016-03-15 2022-02-22 Fresenius Kabi Deutschland Gmbh Cell culture methods for increased cell viability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE751299A (en) * 1970-06-01 1970-11-16 Kakenyaku Kako Kk Dna polyamine compositions for treating - lesions caused by radiation
US4713236A (en) * 1981-12-07 1987-12-15 Morton Thiokol, Inc. Polymeric amine conditioning additives for hair care products
US5300566A (en) * 1988-04-15 1994-04-05 Air Products And Chemicals, Inc. Method for preparing poly(vinyl alcohol)-co-poly(vinylamine) via a two-phase process
US5194492A (en) * 1988-04-15 1993-03-16 Air Products And Chemicals, Inc. Two-phase process for preparing poly(vinyl alcohol)-co-poly(vinylamine)
EP0429842B1 (de) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
US5281307A (en) * 1993-01-13 1994-01-25 Air Products And Chemicals, Inc. Crosslinked vinyl alcohol/vinylamine copolymers for dry end paper addition
AU6254494A (en) * 1993-02-16 1994-09-14 Virginia Tech Intellectual Properties, Inc. Polyelectrolyte dna conjugation and genetic transformation of an animal
US5387641A (en) * 1993-05-25 1995-02-07 Yeung; Dominic W. K. Aqueous polymer emulsions useful as wallcovering prepaste adhesives

Also Published As

Publication number Publication date
JPH11503407A (ja) 1999-03-26
DK0806966T3 (da) 2005-01-03
AU701543B2 (en) 1999-01-28
SI0806966T1 (en) 2005-06-30
IL116887A0 (en) 1996-05-14
ES2233960T3 (es) 2005-06-16
AU4655496A (en) 1996-08-14
EP0806966B1 (de) 2004-11-17
BR9606783A (pt) 1997-12-30
DE69633852T2 (de) 2005-11-03
CA2210875C (en) 2001-05-01
CA2210875A1 (en) 1996-08-01
MX9705536A (es) 1997-10-31
EP0806966A1 (de) 1997-11-19
US5629184A (en) 1997-05-13
WO1996022792A1 (en) 1996-08-01
PT806966E (pt) 2005-03-31
DE69633852D1 (de) 2004-12-23
ZA96401B (en) 1996-08-14

Similar Documents

Publication Publication Date Title
ATE282433T1 (de) Kationische kopolymere von vinylamine und vinylalkohol zur verabreichung von oligonukleotiden
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
ATE264598T1 (de) Methode und vorrichtung zur dynamischen gruppierung von kommunikationseinheiten in einem kommunikationssystem
EP1336600A3 (de) Dimer-selektive rxr Modulatoren und Verfahren zu ihrer Verwendung
CA2312202A1 (fr) Composition cosmetique capillaire sous forme d'emulsion eau-dans-silicone comprenant au moins un polymere fixant
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
PT817847E (pt) Receptor de il-17
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
FR2755608B1 (fr) Composition cosmetique comprenant un polymere anionique ou non ionique et une silicone carboxylique
JP2001506668A5 (de)
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
TR199700720A3 (tr) Yüksek vinil içerige sahip hidrojenlenmis stiren-butadien-stiren blok kopolimerler ihtiva eden petrol jeli formülasyonlari.
MX9708401A (es) Genes reguladores de la cromatina.
SE9702385D0 (sv) Method and device in data network
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
CA2131565A1 (en) Organopolysiloxanes Containing Hydrophilic Groups
DE69510162T2 (de) Hydrierte Polybutadien-Blockcopolymer enthaltende Polymermischungen
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
IL149810A0 (en) Method of enhancing immune responses to herpes simplex virus vaccine
ES2172682T3 (es) Preparaciones desodorantes con contenido en quitosano, clorohidrato de aluminio e inhibidores de esterasa.
TR199701335T1 (xx) Diatomlu toprak ha�erat bile�imi
HUT77250A (hu) Bitumenkompozíciók, valamint azok előállítása és alkalmazása
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0806966

Country of ref document: EP

REN Ceased due to non-payment of the annual fee